short term clinical outcome of percutaneous vertebroplasty

Phase 2

• Conditions: Condition 1: Metastasis to vertebrae with or without compression. Condition 2: Osteoporosis with compression fracture. Condition 3: Multiple Myeloma of vertebrae with or without compression. Condition 4: Hemangioma of vertebrae with or without compression.; metastasis to vertebrae; osteoporosis with compression fracture; Multiple Myeloma of vertebrae; hemangioma of vertebrae

• Registration Number: IRCT138902033778N1
• Lead Sponsor: Research department of Tabriz university of medical sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

inclusion criteria:
-age over 50 years
-osteoporotic compression fracture of vertebrae
-painful vertebral hemangioma
-painful vertebral metastasis
-painful vertebral involvement by multiple myeloma
exclusion criteria:
-new vertebral fractures(less than 2 weeks)
-old vertebral fractures(more than one year)
-sever compression of vertebral body(reduction of more than 80% percent of height of the vertebra)
-myelopathy
-focal neurologic defects
-bleeding disorders

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain. Timepoint: one month after cement injection. Method of measurement: Visual Analogue Scale.

Secondary Outcome Measures

Name	Time	Method
Functional disability after vertebroplasty. Timepoint: immediately , one week and one month after injection of cement. Method of measurement: Oswestry Low Back Pain Questionare.